Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase before EVT in late-window acute ischemic stroke
NCT06221371Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2024
- Primary completion
- Oct 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jan 2024; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06221371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06221371.